164 related articles for article (PubMed ID: 9618650)
1. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Timmer A; Sutherland LR; Martin F
Gastroenterology; 1998 Jun; 114(6):1143-50. PubMed ID: 9618650
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing first relapse in patients with Crohn's disease.
Wright JP
J Clin Gastroenterol; 1992 Jul; 15(1):12-6. PubMed ID: 1500656
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study.
Cosnes J; Carbonnel F; Carrat F; Beaugerie L; Gendre JP
Gut; 1999 Aug; 45(2):218-22. PubMed ID: 10403733
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptive use and cigarette smoking in Crohn's disease.
Katschinski B; Fingerle D; Scherbaum B; Goebell H
Dig Dis Sci; 1993 Sep; 38(9):1596-600. PubMed ID: 8359069
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study.
Lashner BA; Kane SV; Hanauer SB
Gastroenterology; 1989 Dec; 97(6):1442-7. PubMed ID: 2583410
[TBL] [Abstract][Full Text] [Related]
6. Smoking, use of oral contraceptives, and medical induction of remission were risk factors for relapse in Crohn's disease.
Logan RF
Gut; 1999 Mar; 44(3):311-2. PubMed ID: 10026312
[No Abstract] [Full Text] [Related]
7. Epidemiology of Crohn's Disease.
Sandler RS; Golden AL
J Clin Gastroenterol; 1986 Apr; 8(2):160-5. PubMed ID: 3745850
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group.
Sutherland LR; Martin F; Bailey RJ; Fedorak RN; Poleski M; Dallaire C; Rossman R; Saibil F; Lariviere L
Gastroenterology; 1997 Apr; 112(4):1069-77. PubMed ID: 9097988
[TBL] [Abstract][Full Text] [Related]
10. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
[TBL] [Abstract][Full Text] [Related]
11. Smoking, the oral contraceptive pill, and Crohn's disease.
Wakefield AJ; Sawyerr AM; Hudson M; Dhillon AP; Pounder RE
Dig Dis Sci; 1991 Aug; 36(8):1147-50. PubMed ID: 1864207
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of inflammatory bowel disease associated with oral contraceptive use.
Boyko EJ; Theis MK; Vaughan TL; Nicol-Blades B
Am J Epidemiol; 1994 Aug; 140(3):268-78. PubMed ID: 8030630
[TBL] [Abstract][Full Text] [Related]
13. Evidence for an increased risk of Crohn's disease in oral contraceptive users.
Lesko SM; Kaufman DW; Rosenberg L; Helmrich SP; Miller DR; Stolley PD; Shapiro S
Gastroenterology; 1985 Nov; 89(5):1046-9. PubMed ID: 4043662
[TBL] [Abstract][Full Text] [Related]
14. Effect of oral contraceptive use on reoperation following surgery for Crohn's disease.
Sutherland LR; Ramcharan S; Bryant H; Fick G
Dig Dis Sci; 1992 Sep; 37(9):1377-82. PubMed ID: 1505289
[TBL] [Abstract][Full Text] [Related]
15. Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study.
Logan RF; Kay CR
Int J Epidemiol; 1989 Mar; 18(1):105-7. PubMed ID: 2722351
[TBL] [Abstract][Full Text] [Related]
16. [Smoking and ovulation inhibitor in inflammatory bowel diseases].
Katschinski B
Med Klin (Munich); 1993 Feb; 88 Suppl 1():5-8. PubMed ID: 8464399
[TBL] [Abstract][Full Text] [Related]
17. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission.
Kane SV; Flicker M; Katz-Nelson F
J Clin Gastroenterol; 2005 Jan; 39(1):32-5. PubMed ID: 15599207
[TBL] [Abstract][Full Text] [Related]
18. Association Between Long-term Oral Contraceptive Use and Risk of Crohn's Disease Complications in a Nationwide Study.
Khalili H; Granath F; Smedby KE; Ekbom A; Neovius M; Chan AT; Olen O
Gastroenterology; 2016 Jun; 150(7):1561-1567.e1. PubMed ID: 26919969
[TBL] [Abstract][Full Text] [Related]
19. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain.
Sicilia B; López Miguel C; Arribas F; López Zaborras J; Sierra E; Gomollón F
Dig Liver Dis; 2001 Dec; 33(9):762-7. PubMed ID: 11838611
[TBL] [Abstract][Full Text] [Related]
20. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY
Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
